Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Egenskap
Slow movements
Klinisk navn: Bradykinesia
Bradykinesia literally means slow movement, and is used clinically to denote a slowness in the execution of movement (in contrast to hypokinesia, which is used to refer to slowness in the initiation of movement).
Sammendrag
- Også kalt
- Slowness of movements
- Kroppssystem
- Abnormality of the nervous system
Slow movementsHP:0002067
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Read the genes linked to Slow movements, and the rest of your genome, with one test.
Fra 449 $Gratis frakt · Resultater på 6–8 uker
Få mitt Genome Test130 gener knyttet til Slow movements
Endringer i disse genene forårsaker sjeldne tilstander der Slow movements forekommer. De fleste med denne egenskapen har ingen av disse tilstandene, og et gen på denne listen sier ingenting om noens eget genom.
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| AHDC1AT-hook DNA binding motif containing 1 | Alltid | I 1 tilstand |
| ATP13A2ATPase cation transporting 13A2 | Alltid | I 4 tilstander |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Alltid | I 3 tilstander |
| ATP6AP2ATPase H+ transporting accessory protein 2 | Alltid | I 3 tilstander |
| DNAJC6DnaJ heat shock protein family (Hsp40) member C6 | Alltid | I 3 tilstander |
| EIF2AK1eukaryotic translation initiation factor 2 alpha kinase 1 | Alltid | I 1 tilstand |
| EPG5ectopic P-granules 5 autophagy tethering factor | Alltid | I 1 tilstand |
| HTThuntingtin | Alltid | I 4 tilstander |
| LRRC7leucine rich repeat containing 7 | Alltid | I 1 tilstand |
| MAPTmicrotubule associated protein tau | Alltid | I 6 tilstander |
| MECP2methyl-CpG binding protein 2 | Alltid | I 2 tilstander |
| MYORGmyogenesis regulating glycosidase | Alltid | I 3 tilstander |
| PARK7Parkinsonism associated deglycase | Alltid | I 2 tilstander |
| PDE8Bphosphodiesterase 8B | Alltid | I 2 tilstander |
| PET117PET117 cytochrome c oxidase chaperone | Alltid | I 1 tilstand |
| PLA2G6phospholipase A2 group VI | Alltid | I 3 tilstander |
| POLGDNA polymerase gamma, catalytic subunit | Alltid | I 4 tilstander |
| PRKNparkin RBR E3 ubiquitin protein ligase | Alltid | I 2 tilstander |
| PTRHD1peptidyl-tRNA hydrolase domain containing 1 | Alltid | I 1 tilstand |
| RAB32RAB32, member RAS oncogene family | Alltid | I 1 tilstand |
| RAB39BRAB39B, member RAS oncogene family | Alltid | I 1 tilstand |
| SNCAsynuclein alpha | Alltid | I 4 tilstander |
| SYNJ1synaptojanin 1 | Alltid | I 3 tilstander |
| UQCRC1ubiquinol-cytochrome c reductase core protein 1 | Alltid | I 1 tilstand |
| CHCHD2coiled-coil-helix-coiled-coil-helix domain containing 2 | Svært ofte (80–99 %) | I 1 tilstand |
| NIT1nitrilase 1 | Svært ofte (80–99 %) | I 1 tilstand |
| PODXLpodocalyxin like | Svært ofte (80–99 %) | I 2 tilstander |
| SLC6A3solute carrier family 6 member 3 | Svært ofte (80–99 %) | I 2 tilstander |
| ACTA1actin alpha 1, skeletal muscle | Ofte (30–79 %) | I 1 tilstand |
| ATCAYATCAY kinesin light chain interacting caytaxin | Ofte (30–79 %) | I 1 tilstand |
| ATXN1ataxin 1 | Ofte (30–79 %) | I 1 tilstand |
| ATXN10ataxin 10 | Ofte (30–79 %) | I 1 tilstand |
| ATXN8ataxin 8 | Ofte (30–79 %) | I 1 tilstand |
| ATXN8OSATXN8 opposite strand lncRNA | Ofte (30–79 %) | I 2 tilstander |
| CMPK2cytidine/uridine monophosphate kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| COQ2coenzyme Q2, polyprenyltransferase | Ofte (30–79 %) | I 3 tilstander |
| EIF2AK2eukaryotic translation initiation factor 2 alpha kinase 2 | Ofte (30–79 %) | I 1 tilstand |
| FBXO7F-box protein 7 | Ofte (30–79 %) | I 2 tilstander |
| FGF13fibroblast growth factor 13 | Ofte (30–79 %) | I 2 tilstander |
| FTLferritin light chain | Ofte (30–79 %) | I 2 tilstander |
Vis 90 gener til
| Gen | Hvor ofte den forekommer | Tilstander |
|---|---|---|
| GABRA1gamma-aminobutyric acid type A receptor subunit alpha1 | Ofte (30–79 %) | I 1 tilstand |
| GABRG2gamma-aminobutyric acid type A receptor subunit gamma2 | Ofte (30–79 %) | I 2 tilstander |
| GCH1GTP cyclohydrolase 1 | Ofte (30–79 %) | I 2 tilstander |
| JAM2junctional adhesion molecule 2 | Ofte (30–79 %) | I 3 tilstander |
| KBTBD13kelch repeat and BTB domain containing 13 | Ofte (30–79 %) | I 1 tilstand |
| KLHL41kelch like family member 41 | Ofte (30–79 %) | I 1 tilstand |
| MYPNmyopalladin | Ofte (30–79 %) | I 1 tilstand |
| NAA60N-alpha-acetyltransferase 60, NatF catalytic subunit | Ofte (30–79 %) | I 2 tilstander |
| NEBnebulin | Ofte (30–79 %) | I 1 tilstand |
| NR4A2nuclear receptor subfamily 4 group A member 2 | Ofte (30–79 %) | I 3 tilstander |
| PCDH19protocadherin 19 | Ofte (30–79 %) | I 1 tilstand |
| PDGFBplatelet derived growth factor subunit B | Ofte (30–79 %) | I 2 tilstander |
| PDGFRBplatelet derived growth factor receptor beta | Ofte (30–79 %) | I 2 tilstander |
| POLG2DNA polymerase gamma 2, accessory subunit | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Bprotein kinase cAMP-dependent type I regulatory subunit beta | Ofte (30–79 %) | I 1 tilstand |
| PRKRAprotein activator of interferon induced protein kinase EIF2AK2 | Ofte (30–79 %) | I 2 tilstander |
| PRNPprion protein (Kanno blood group) | Ofte (30–79 %) | I 3 tilstander |
| PTPAprotein phosphatase 2 phosphatase activator | Ofte (30–79 %) | I 1 tilstand |
| RAB3ARAB3A, member RAS oncogene family | Ofte (30–79 %) | I 1 tilstand |
| RRM2Bribonucleotide reductase regulatory TP53 inducible subunit M2B | Ofte (30–79 %) | I 1 tilstand |
| RRP12ribosomal RNA processing 12 homolog | Ofte (30–79 %) | I 2 tilstander |
| SCN1Asodium voltage-gated channel alpha subunit 1 | Ofte (30–79 %) | I 2 tilstander |
| SCN1Bsodium voltage-gated channel beta subunit 1 | Ofte (30–79 %) | I 2 tilstander |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Ofte (30–79 %) | I 2 tilstander |
| SCN9Asodium voltage-gated channel alpha subunit 9 | Ofte (30–79 %) | I 2 tilstander |
| SLC20A2solute carrier family 20 member 2 | Ofte (30–79 %) | I 2 tilstander |
| SLC25A4solute carrier family 25 member 4 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A3solute carrier family 2 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC30A10solute carrier family 30 member 10 | Ofte (30–79 %) | I 2 tilstander |
| SLC39A14solute carrier family 39 member 14 | Ofte (30–79 %) | I 2 tilstander |
| SLC9A6solute carrier family 9 member A6 | Ofte (30–79 %) | I 1 tilstand |
| SPRsepiapterin reductase | Ofte (30–79 %) | I 1 tilstand |
| TAF1TATA-box binding protein associated factor 1 | Ofte (30–79 %) | I 1 tilstand |
| THtyrosine hydroxylase | Ofte (30–79 %) | I 1 tilstand |
| TPM2tropomyosin 2 | Ofte (30–79 %) | I 1 tilstand |
| TPM3tropomyosin 3 | Ofte (30–79 %) | I 1 tilstand |
| TSPOAP1TSPO associated protein 1 | Ofte (30–79 %) | I 1 tilstand |
| TWNKtwinkle mtDNA helicase | Ofte (30–79 %) | I 1 tilstand |
| WARS2tryptophanyl tRNA synthetase 2, mitochondrial | Ofte (30–79 %) | I 1 tilstand |
| WDR45WD repeat domain 45 | Ofte (30–79 %) | I 2 tilstander |
| XPR1xenotropic and polytropic retrovirus receptor 1 | Ofte (30–79 %) | I 2 tilstander |
| ATP5MKATP synthase membrane subunit k | Noen ganger (5–29 %) | I 1 tilstand |
| CLTCclathrin heavy chain | Noen ganger (5–29 %) | I 1 tilstand |
| DNAJC13DnaJ heat shock protein family (Hsp40) member C13 | Noen ganger (5–29 %) | I 1 tilstand |
| EIF4G1eukaryotic translation initiation factor 4 gamma 1 | Noen ganger (5–29 %) | I 2 tilstander |
| FARS2phenylalanyl-tRNA synthetase 2, mitochondrial | Noen ganger (5–29 %) | I 1 tilstand |
| FMR1fragile X messenger ribonucleoprotein 1 | Noen ganger (5–29 %) | I 2 tilstander |
| GBA1glucosylceramidase beta 1 | Noen ganger (5–29 %) | I 2 tilstander |
| GIGYF2GRB10 interacting GYF protein 2 | Noen ganger (5–29 %) | I 2 tilstander |
| HTRA2HtrA serine peptidase 2 | Noen ganger (5–29 %) | I 2 tilstander |
| IMPDH2inosine monophosphate dehydrogenase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| KCNN2potassium calcium-activated channel subfamily N member 2 | Noen ganger (5–29 %) | I 1 tilstand |
| LRRK2leucine rich repeat kinase 2 | Noen ganger (5–29 %) | I 3 tilstander |
| PIDD1p53-induced death domain protein 1 | Noen ganger (5–29 %) | I 1 tilstand |
| PINK1PTEN induced kinase 1 | Noen ganger (5–29 %) | I 2 tilstander |
| PPP2R2Bprotein phosphatase 2 regulatory subunit Bbeta | Noen ganger (5–29 %) | I 1 tilstand |
| PRDX3peroxiredoxin 3 | Noen ganger (5–29 %) | I 1 tilstand |
| PTS6-pyruvoyltetrahydropterin synthase | Noen ganger (5–29 %) | I 2 tilstander |
| RRM1ribonucleotide reductase catalytic subunit M1 | Noen ganger (5–29 %) | I 1 tilstand |
| TACO1translational activator of cytochrome c oxidase I | Noen ganger (5–29 %) | I 1 tilstand |
| TK2thymidine kinase 2 | Noen ganger (5–29 %) | I 1 tilstand |
| TOP3ADNA topoisomerase III alpha | Noen ganger (5–29 %) | I 1 tilstand |
| TTC19tetratricopeptide repeat domain 19 | Noen ganger (5–29 %) | I 1 tilstand |
| UCHL1ubiquitin C-terminal hydrolase L1 | Noen ganger (5–29 %) | I 2 tilstander |
| VPS13Avacuolar protein sorting 13 homolog A | Noen ganger (5–29 %) | I 1 tilstand |
| VPS13Cvacuolar protein sorting 13 homolog C | Noen ganger (5–29 %) | I 1 tilstand |
| VPS35VPS35 retromer complex component | Noen ganger (5–29 %) | I 2 tilstander |
| ADGRV1adhesion G protein-coupled receptor V1 | Sjelden (1–4%) | I 1 tilstand |
| ATL1atlastin GTPase 1 | Sjelden (1–4%) | I 1 tilstand |
| CPA6carboxypeptidase A6 | Sjelden (1–4%) | I 1 tilstand |
| GABRDgamma-aminobutyric acid type A receptor subunit delta | Sjelden (1–4%) | I 1 tilstand |
| HCN1hyperpolarization activated cyclic nucleotide gated potassium channel 1 | Sjelden (1–4%) | I 1 tilstand |
| KCNC3potassium voltage-gated channel subfamily C member 3 | Sjelden (1–4%) | I 1 tilstand |
| PRRT2proline rich transmembrane protein 2 | Sjelden (1–4%) | I 1 tilstand |
| SLC32A1solute carrier family 32 member 1 | Sjelden (1–4%) | I 1 tilstand |
| STX1Bsyntaxin 1B | Sjelden (1–4%) | I 1 tilstand |
| ADH1Calcohol dehydrogenase 1C (class I), gamma polypeptide | Ikke registrert | I 1 tilstand |
| ATXN2ataxin 2 | Ikke registrert | I 2 tilstander |
| ATXN3ataxin 3 | Ikke registrert | I 2 tilstander |
| COASYCoenzyme A synthase | Ikke registrert | I 1 tilstand |
| CSF1Rcolony stimulating factor 1 receptor | Ikke registrert | I 1 tilstand |
| DCTN1dynactin subunit 1 | Ikke registrert | I 1 tilstand |
| DHDDSdehydrodolichyl diphosphate synthase subunit | Ikke registrert | I 1 tilstand |
| DNAJC12DnaJ heat shock protein family (Hsp40) member C12 | Ikke registrert | I 1 tilstand |
| EARS2glutamyl-tRNA synthetase 2, mitochondrial | Ikke registrert | I 1 tilstand |
| JPH3junctophilin 3 | Ikke registrert | I 1 tilstand |
| MT-TTmitochondrially encoded tRNA-Thr (ACN) | Ikke registrert | I 1 tilstand |
| PANK2pantothenate kinase 2 | Ikke registrert | I 1 tilstand |
| SNCAIPsynuclein alpha interacting protein | Ikke registrert | I 1 tilstand |
| TBPTATA-box binding protein | Ikke registrert | I 2 tilstander |
Hvor ofte dette forekommer hos personer med en av genets tilstander, oppgitt som den hyppigste forekomsten blant dem, slik Human Phenotype Ontology registrerer den. Disse sidene beskriver egenskaper og forskningen bak dem. De er ikke en diagnose, og om symptomer bør du spørre lege eller genetisk rådgiver.
Bredere egenskaper
Slik er informasjonen samlet
- Human Phenotype Ontology, versjon 2026-09-01: egenskapen, navnene på den, definisjonen og genene som er knyttet til den. Les mer på hpo.jax.org.
- Datautgave 2026.10.16-c6eea6bf.
Hvem vi hjelperVår vitenskapProdukterResultater
Logg innSpørKom i gangfra 449 $
Én test. En livstid med svar.
Fra 449 $Gratis frakt · Resultater på 6–8 uker